RBF Capital’s Nuvation Bio NUVB Stock Holding History

RBF Capital’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Hold	40,000	–	–	0.01%	468
2026 Q1	$172K	Hold	40,000	–	–	0.01%	467
2025 Q4	$358K	Hold	40,000	–	–	0.02%	452
2025 Q3	$148K	Hold	40,000	–	–	0.01%	543
2025 Q2	$78K	Sell	40,000 -61,561	-61%	-$128K	﹤0.01%	587
2025 Q1	$179K	Hold	101,561	–	–	0.01%	523
2024 Q4	$286K	Sell	101,561 -55,114	-35%	-$142K	0.01%	468
2024 Q3	$398K	Hold	156,675	–	–	0.02%	455
2024 Q2	$457K	Hold	156,675	–	–	0.03%	404
2024 Q1	$570K	Sell	156,675 -5,582	-3%	-$10.7K	0.03%	380
2023 Q4	$245K	Hold	162,257	–	–	0.01%	472
2023 Q3	$217K	Sell	162,257 -15,503	-9%	-$25.8K	0.01%	459
2023 Q2	$322K	Hold	177,760	–	–	0.02%	417
2023 Q1	$294K	Hold	177,760	–	–	0.02%	406
2022 Q4	$339K	Buy	+177,760	New	+$360K	0.03%	393

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

RBF Capital's NUVB Position: Q2 2026 in Review

RBF Capital held its Nuvation Bio (NUVB) position steady in Q2 2026 at 40,000 shares worth $227K. The position accounts for 0.01% of the portfolio, ranked #468.

RBF Capital first reported a position in NUVB in Q4 2022 and has held it in 15 quarters since. The position peaked at $570K in Q1 2024. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

RBF Capital held 40,000 shares of Nuvation Bio worth $227K as of Q2 2026.
RBF Capital left its Nuvation Bio share count unchanged in Q2 2026.
Nuvation Bio made up 0.01% of RBF Capital's portfolio in Q2 2026, its #468 holding.
RBF Capital first reported a position in Nuvation Bio in Q4 2022 and has held it in 15 quarters since.
RBF Capital's Nuvation Bio position peaked at $570K in Q1 2024.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on RBF Capital's 13F filing for Q2 2026, filed 14 Aug 2026.